the real storyGen traded down to a penny because the lawsuit looked like it would bankrupt them. They have a quality product with their biomarker generating over a million dollars in revenue and had a share price over a dollar but their partners dragged them down. If the recent news has settled the legal problems then there is lots of upside but the NR does not address the lawsuit problem directly. Has the lawsuit gone away or is the uptick just a scam with a disaster right around the corner. Not to mention the CEOs past performance. Back to a dollar a share or is the lawsuit an ongoing problem.